News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Crucell N.V. (CRXL) Announces Completion Of Acquisition Of SBL Vaccin AB


11/27/2006 1:39:42 PM

LEIDEN, NETHERLANDS -- (MARKET WIRE) -- November 23, 2006 -- Dutch biotechnology company Crucell N.V. (Euronext: CRXL) (NASDAQ: CRXL) (Swiss Exchange: CRX) announced today that it has completed the acquisition of SBL Vaccin AB.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES